Trial Profile
Phase III Trial of IV Vinflunine Versus an Alkylating Agent in Patients With Metastatic Breast Cancer Previously Treated With or Resistant to an Anthracycline, a Taxane, an Antimetabolite, and a Vinca-alkaloid (Study L00070 IN 308 B0)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Oct 2019
Price :
$35
*
At a glance
- Drugs Vinflunine (Primary) ; Carboplatin; Cisplatin; Cyclophosphamide; Melphalan; Mitomycin; Thiotepa
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Pierre Fabre
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 02 Jun 2015 Status changed from active, no longer recruiting to completed as result presented at 51st Annual Meeting of the American Society of Clinical Oncology.
- 19 Aug 2013 Planned end date changed from 1 Aug 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.